 - Subjects who develop a sufficiently high level of antibodies may at the discretion of the laboratory chief be allowed to work with strains of TBEV at Biosafety Level BSL 3 rather than BSL-4. Blood will be drawn annually for 3 years to determine antibody level and response to the vaccine. Booster doses will be provided if required. 